The aim of this work was to evaluate the effect of uncoupling protein 2 (UCP2) muscle gene transfer on mitochondrial activity. DESIGN: Five week-old male Wistar rats received an intramuscular injection of plasmid pXU1 containing UCP2 cDNA in the right tibialis anterior muscles. Left tibialis anterior muscles were injected with vehicle as control. Ten days after DNA injection, tibialis anterior muscles were dissected and muscle mitochondria isolated and analyzed. RESULTS: There were two mitochondrial populations in the muscle after UCP2 gene transfer, one of low¯uorescence and complexity and the other, showing high¯uorescence and complexity. UCP2 gene transfer resulted in a 3.6 fold increase in muscle UCP2 protein levels compared to control muscles assessed by Western blotting. Furthermore, a signi®cant reduction in mitochondria membrane potential assessed by spectro¯uorometry and¯ow cytometry was observed. The mitochondria membrane potential reduction might account for a decrease in¯uorescence of the low¯uorescence mitochondrial subpopulation. CONCLUSION: It has been demonstrated that UCP2 muscle gene transfer in vivo is associated with a lower mitochondria membrane potential. Our results suggest the potential involvement of UCP2 in uncoupling respiration.
Introduction
Uncoupling proteins (UCPs) are a family of mitochondrial molecules currently implicated as potential modulators of thermoregulation, body composition, metabolism and obesity. 1 ± 8 The ®rst identi®ed member, UCPI is abundantly expressed in brown adipose tissue (BAT), where it increases proton conductivity of the inner mitochondria membrane and enables regulatory heat production at the expense of ATP synthesis. 9 Protonophoric activity of UCP1 is in¯uenced by fatty acids and purine nucleotides. 10 ± 13 Other members of the UCP family recently identi®ed are UCP2, UCP3 and UCP4 or brain mitochondrial carrier protein (BMCP1).
3,5 ± 8,14 ± 18 UCP2 is expressed in many tissues and organs such as white adipose tissue (WAT), skeletal muscle, immune system, lung, brain, kidney, heart, pancreas and liver. 3,5,14,19,20, It bears a high degree of sequence homology to UCP1 and UCP3 (59% and 73%, respectively) and a lower level of similarity (33 ± 38%) to the novel UCP family member, UCP4 or BMCP1. 17, 18 UCP2 expression in WAT is up-regulated by leptin 21 ± 23 and high-fat diet intake 3, 5, 24 as a putative mediator in thermogenesis, and is constitutively up-regulated in obaob and dbadb mice, which suggests a compensatory role of this isoform in severe genetic obesity. 5 Furthermore, animals under cold exposure or fasting also showed higher UCP2 expression in muscle and BAT. 2, 25 It also has been reported that UCP2 stimulation depends on PPARa and g activation in BAT and several cell lines. 26 ± 28 Moreover, UCP2 may be involved in fever, infection and in the defense against the generation of reactive oxygen species. 29, 30 Recently, much effort has been directed toward understanding the molecular mechanisms of energy expenditure and its regulation. Mitochondrial proton leak has been observed in the major oxygen-consuming tissues, including liver, kidney, brain and muscle, contributing substantially to the standard metabolic rate. 31 ± 34 Similar to UCP1, UCP2 overexpression in yeast could depolarize the inner mitochondrial membrane 3, 5 and appears to be regulated by retinoids in a pH-dependent manner. 35 However the protonophoric function of UCP2 in mammalian cells is still controversial.
Intramuscular injection is a useful method of gene transfer. After injection, naked DNA is taken up by myo®bers and subsequently expresses exogenous genes. 36, 37 This method has already been used to study the metabolic effects of genes involved in energy regulation. 38, 39 Here, the potential usefulness of muscle gene injection to elucidate UCP2 function on mitochondrial activity is reported.
Materials and methods

Animals procedures
Five week-old male Wistar rats were obtained from the Center of Applied Pharmacology (CIFA, Spain). Twenty animals were initially kept at 23 C on a 12 : 12 h light ± dark cycle and had free access to food and water. After an adaptation period, animals were anesthesied with Ketamine (100 mgakg i.p., Parke-Davis, Barcelona, Spain) and Xylazine (10 mgakg i.p., Bayer, Leverkusen, Germany) and received an intramuscular injection of plasmid pXU1 (containing the uncoupling protein 2 cDNA under the control of the cytomagolovirus (CMV) promoter and myosin light chain 1a3 enhancer), formulated in polyvinyl-pyrrolidone (1 : 17 waw) and 150 mM NaCl. 40 Left tibialis anterior muscles were injected with vehicle as control. Right tibialis anterior muscles were injected percutaneously with 100 ml of the formulation containing 75 mg DNA. Ten days after DNA injection, the animals were killed and tibialis anterior muscles were quickly removed and immediately processed. All animal care and experimental procedures were performed under the guidelines of the University Committee for Animal Care and Use and national regulations.
Mitochondria preparations and Western blotting analysis
Tibialis muscles were carefully minced with scissors, rinsed thoroughly in isolation buffer (1 : 10 volavol) and homogenized for 25 s in a Potter Elvehjem homogenizer. 41 For Flow cytometry (FCM) analysis 0.4 mgaml of nagarse protease (Sigma, St Louis, USA) was added to the isolation buffer containing 100 mM sucrose, 100 mM KCI, 1 mM KH 2 PO 4 , 0.2% BSA, 50 mM Tris HC1 and 0.1 mM EGTA, pH 7.4. 42 The homogenate was diluted and centrifuged at 700 Â g for 10 min. The supernatant was centrifuged at 10 000 Â g for 10 min four times. The ®nal mitochondria pellet was resuspended in a minimal volume and kept on ice.
Extracts were sonicated (Branson Soni®er 250, Danbury, USA) and normalized for protein prior to loading into the gel for Western blotting analysis. Samples were electrophoretically separated in 12% SDS-PAGE and electrotransferred to PVDF membranes. Membranes were incubated overnight with a polyclonal rabbit UCP2 antibody raised against a 13-amino acid sequence mapping between the 3rd and 4th transmembrane domains of rat UCP2, purchased from Alpha Diagnostics International (Texas, USA). Secondary goat anti-rabbit antibodies were used and blots were developed by chemiluminiscent detection (ECL, Amersham, Madrid, Spain). Protein bands were analyzed by densitometry with the Image Master Software (Pharmacia Biotech, Uppsala, Sweden).
Estimation of mitochondrial membrane potential
Mitochondrial membrane potential was evaluated in UCP2-injected and control muscles as previously described 43, 44 using rhodamine 123 dye at 1 mM ®nal concentration. For state 2 conditions, mitochondria at a concentration of 1 mgaml were incubated with 5 mM rotenone and energized with 5 mM sodium succinate. Studies adding ADP (0.4 mM, state 3) and the uncoupler carbonylcyanide m-chlorophenylhydrazone (CCCP) (1 mM, state 4) were performed to con®rm that the uptake of rhodamine was related to mitochondrial membrane potential.
In a group of mitochondria preparations, rhodamine uptake was analyzed after 15 min incubation in a spectrouorometer (Perkin Elmer LS50), with an excitation wavelength of 500 nm and emission at 523 nm. 19 Membrane potential measurements and mitochondria population characterization (low¯uorescence population (LFP) and high uorescence population (HFP)) were performed in a second group of mitochondria preparations by FCM. Fluorochrome was excited with an argon laser tuned at 488 nm and 90 right-angle side scatter (SS) was collected through a 488 nm blocking ®lter, a 550 nm long-pass dichroic, and a 525 nm band-pass. Gated regions were chosen by FCM, 45 ± 47 based on uorescence intensity and side scatter parameters within mitochondria samples, which allowed the calculation of percentages of HFP and LFP.
The¯uorescence intensity of rhodamine re¯ecting a minimum of 15 000 individual mitochondria per sample was analyzed in an Epics XL¯ow cytometer (Coulter Electronics, FL, USA) using System II version 2.1. Software. Fluorescence intensity was expressed as the integral of green-¯uorescence in a three-order log scale (IGFL).
Statistical analysis
Differences between groups were analyzed using paired or unpaired t-test as appropriate. All analyses were performed by using the SPSS version 6.1.3 (SPSS Inc, Chicago, USA) statistical package. 48 
Results
After a single intramuscular injection of an expression plasmid containing UCP2 cDNA, mitochondrial UCP2 expression was increased. A higher intensity band of about 32 kD Effect of UCP2 muscle gene transfer A Marti et al (3.6 fold, P`0.05) was observed in UCP2-injected muscles when compared to control (Figure 1) by Western blotting analysis.
Mitochondria respiratory activity was measured using succinate as substrate. To allow only oxidation of this¯avo-protein-coupled substrate, the respiratory medium contained rotenone, which inhibits NADH-linked respiration (ie fatty acid oxidation). FCM analysis showed that after energization of the mitochondrial suspensions, a 5-fold increase in membrane potential was achieved in mitochondria from both control and UCP2-injected muscles ( Figure  2B ). As expected, the addition of ADP was accompanied by a partial reduction of the membrane potential in both UCP2-injected and control muscles ( Figure 2C ), while addition of CCCP (a protonophore) collapsed the membrane potential ( Figure 2D ). As shown in Figure 2B , UCP2-injected muscles showed a signi®cant reduction (À11%; P`0.05) in mitochondrial electrochemical potential (state 2) when compared to controls (see also Figure 3A and Table 1 ). This result was further con®rmed in a separate experiment by spectro¯uoro-metry ( Figure 3B ), in which rhodamine uptake was signi®-cantly reduced in UCP2-injected muscles compared to controls (65 AE 2 vs 100 AE 14; P`0.05). However, no statistically signi®cant differences were found between control and UCP2-injected muscles after ADP or CCCP addition.
In agreement with other reports concerning FCM analysis of isolated mitochondria stained with rhodamine, 43 muscle mitochondria preparations showed two different¯uores-cence peaks, representing a major LFP and a minor HFP subpopulation. After being selected with the aid of the software program, the percentage and¯uorescence intensity of HFP and LFP in the gated regions were estimated in mitochondria preparations from control and UCP2-injected muscles (` Table 1 ). The percentage of the most abundant population (LFP) was similar in mitochondria from control and UCP2-injected muscles and did not change with the energy status. The percentage of the HFP tended to be lower in mitochondria preparations from UCP2-injected muscles regardless of the energy status. However, the signi®cant decrease in membrane potential observed in mitochondria from UCP2-injected muscles (state 2) can be accounted for by the decrease in¯uorescence intensity (Control: 3.37 AE 0.18 vs UCP2: 2.99 AE 0.18) of the LFP subpopulation (Table 1) , even though the percentage of the LFP subpopulation is not signi®cantly different.
Discussion
To our knowledge, this is the ®rst description of an in vivo reduction in mitochondrial membrane potential after a single muscle injection of the UCP2 gene. In other gene transfer studies, important systemic as well as local effects were achieved by ectopically expressed proteins. 38, 39 This procedure is safer, has reduced immunogenicity 37 and has been shown to be more ef®cient than some viral vectors in targeting the mature muscle ®bers of rodents. 49 However, the main disadvantage is that naked DNA has a relatively low transfer ef®ciency and it is dif®cult to assess the number and localization of transfected muscle ®bers. Even so, we have been able to con®rm by Western blot that mitochondria from UCP2-injected muscles had higher UCP2 levels. Nevertheless, it remains to be elucidated whether UCP2 expression occurs in mitochondria located directly beneath the sarcolemma (subsarcolemmal mitochondria) andaor between the myo®brils (inter®brillar mitochondria).
The role of UCP2 as an uncoupling protein in mammalian cells has been the subject of much debate. So far, most of the studies reporting a decrease in mitochondrial membrane potential, higher oxygen consumption or proton conductance were performed in yeast overexpressing the UCP2 protein. 3, 5, 50 Interestingly, there are few articles in which it has been demonstrated that UCP2 functions as an uncoupler in mammalian systems. An association between UCP2 expression and increase of proton leak of the mitochondrial inner membrane was found for the ®rst time in the liver of obaob mice by Chavin et al. 51 Other investigators working in primary cultured hepatocytes reported a 60% decrease in mitochondrial membrane potential and a 166% increase in the ratio of oxygen consumption rate due to UCP2 expression. 50 However, Cadenas et al 52 demonstrated that changes in UCP2 mRNA levels due to starvation were not followed by any modi®cation in mitochondrial proton conductance. 
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In the present study, mitochondrial activity was evaluated after rhodamine uptake, which selectively stains mitochondria depending on membrane potential. 43, 44 A decrease in mitochondria membrane potential in UCP2-injected muscles compared to control muscles was observed by spectro-¯u orometry. A similar reduction in mitochondrial membrane potential when overexpressing either UCP3 or UCP4 in mammalian cells 17 was also found using spectrouorometry. However, to avoid the disadvantages of assessing¯uorescence of bulk suspensions, we performed FCM, in This type of analysis requires low amounts of the probe or biological samples, and allows the selection of gated regions.
To improve mitochondrial preparations for FCM, tissue minces were exposed to nagarse treatment whereby inter®-brillar mitochondria are released and greater yields of muscle mitochondrial protein are achieved. 41 In our study, the observed reduction in mitochondria membrane potential after UCP2 gene transfer assessed by spectro¯uorometry could be con®rmed by FCM. A similar decrease was also obtained by FCM in yeast or myoblasts overexpressing UCP2 or UCP3 3, 5, 7, 8, 53, 54 or even in adipocytes from transgenic mice overexpressing UCP1. 55 Moreover, we observed that GDP addition to mitochondrial preparations did not change mitochondria membrane potential analyzed by FCM, in muscles expressing UCP2 (data not shown), which is in agreement with recent reports. 35, 56 The results may indicate that residues that have been shown to be critical for purine nucleotide inhibition in UCP1 and that are present in UCP2, are not suf®cient for high sensitivity to nucleotide inhibition.
A¯uorescence-associated mitochondria population distribution has been postulated. Rat liver mitochondria stained with rhodamine revealed the occurrence of two distinct mitochondrial populations with HFP or LFP¯uorescence intensities. 43 Both mitochondrial populations have been observed in vivo in different developmental states 57 and in hepatocytes from primary cultures. 31 The most abundant population (LFP) has lower size and side scatter than the less abundant population (HFP), which represent a more immature and fragile compartment of mitochondria with less functionality. 43, 47 Likewise, several studies 41, 58 support the notion that, in muscle, there are two mitochondrial populations according to the net mitochondrial inner membrane potential measured by relative rhodamine¯uorescence intensity. We studied mitochondria population heterogeneity after UCP2 gene transfer and could identify two different populations, one of low¯uorescence and complexity (LFP) and another showing high¯uorescence and complexity (HFP). Although the percentage of the two mitochondrial populations was similar in control and UCP2-injected muscles, the¯uores-cence of the LFP was signi®cantly lower in UCP2-injected muscles than in control muscles after energization with succinate. Such a difference was not detected for the HFP population, suggesting that the major LFP was responsible for the signi®cant overall decrease in membrane potential found in mitochondria isolated from UCP2-injected muscles.
Our ®ndings provide a useful model to study the in vivo effects of other members of the UCP family on mitochondrial function. Further studies are required to investigate the potential changes in oxygen consumption and its contribution to energy expenditure after the gene transfer procedure. Effect of UCP2 muscle gene transfer A Marti et al
